QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CNMD

QT64CONMED Corporation
NYSE·Healthcare·Medical - Devices·USA
Latest market price
32.58
+0.47+1.46%
OverviewShort InterestFilings
CNMDQT64CONMED Corporation·NYSE
OverviewShort InterestFilings
32.58+1.46%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E17.91EPS (ttm)1.77
Insider Own2.72%
Shs Outstand30.11M
Perf Week-5.32%
Market Cap966.81MForward P/E6.80EPS next Y4.79Insider Trans0.00%Shs Float-Perf Month-9.95%
Enterprise Value1.79BPEG-EPS next Q1.10Inst Own-Short Float-Perf Quarter-11.47%
Income53.95MP/S0.70EPS this Y146.61%Inst Trans-Short Ratio-Perf Half Y-16.89%
Sales1.37BP/B0.97EPS next Y9.70%ROA2.37%Short Interest-Perf YTD-19.75%
Book/sh33.81P/C6.89EPS next 5Y11.51%ROE5.40%52W High56.64 -42.48%Perf Year-37.63%
Cash/sh1.16P/FCF7.82EPS past 3/5Y-ROIC5.08%52W Low31.84 2.32%Perf 3Y-
Dividend Est.0.20 (0.61%)EV/EBITDA10.57Sales past 3/5Y9.55% 9.77%Gross Margin53.58%Volatility3.30% 3.14%Perf 5Y-
Dividend TTM0.20 (0.61%)EV/Sales1.31EPS Y/Y TTM6.81%Oper. Margin11.18%ATR (14)1.68Perf 10Y-
Dividend Ex-DateSep 15, 2025Quick Ratio1.04Sales Y/Y TTM4.97%Profit Margin4.00%RSI (14)39.31Recom2.67
Dividend Gr. 3/5Y-9.14% -5.59%Current Ratio2.29EPS Q/Q-6.32%SMA20-6.80%Beta1.07Target Price78.00
Payout33.85%Debt/Eq0.85Sales Q/Q-0.63%SMA50-10.34%Rel Volume2.54Prev Close32.11
Employees3,900LT Debt/Eq0.81EarningsJul 29SMA200-21.27%Avg Volume483.19KPrice32.58
IPO DateJul 23, 1987Option/ShortYes / YesEPS/Sales Surpr.8.54% 1.93%Net Debt/EBITDA4.87Volume1,228,142Change1.46%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-17-26DowngradePiper SandlerOverweight → Neutral
Jun-12-25DowngradeNeedhamBuy → Hold
May-01-25ReiteratedNeedhamBuy$97 → $61
Apr-28-25DowngradeStifelBuy → Hold
Feb-06-25DowngradeJP MorganOverweight → Neutral
Oct-04-24ReiteratedNeedhamBuy$107 → $97
Apr-25-24ReiteratedPiper SandlerOverweight$108 → $95
Apr-25-24ReiteratedNeedhamBuy$107
Mar-27-23UpgradeKeybancSector Weight → Overweight
Oct-26-22ReiteratedPiper SandlerOverweight$118 → $108
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,3721,3741,307
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A638649574
Gross Profit735725733
Selling, General and Administrative Excl. Other524528478
Research and Development595654
Other Operating Expense-101
Operating Income153141200
Interest Expense303137
Unusual Expense
———
Non-Operating Income (Expense)42390
Net Income Before Taxes8171163
Income Taxes272431
Consolidated Net Income5547132
Net Income From Continuing Operations5547132
Net Income5547132
EPS (Recurring)1.771.524.29
EPS (Basic, Before Extraordinaries)1.771.524.29
EPS (Diluted)1.771.514.26
EBITDA169155272
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio18.4126.89—
Price To Sales Ratio0.740.92—
Gross Margin53.5752.7756.08
Operating Margin11.1510.2615.30
Net Margin4.013.4210.10
Shares Outstanding313131
Market Capitalization1,0101,259—
Operating Lease Expense
———
Insider Trading Volume
$35.86$32.19$28.52$24.86$21.19● Close Price0.00K40.27K80.55K120.82K161.09KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Lalomia BrentExecutive VP RA, QAMar 06 '26Option Exercise0.001500941Mar 10 12:00 AM
Kaye MarkDirectorFeb 24 '26Option Exercise0.003040152Feb 26 12:00 AM
Glaze RichardChief Information OfficerNov 21 '25Sale41.2125710,5910Nov 24 12:00 AM
Glaze RichardChief Information OfficerNov 20 '25Option Exercise0.007500750Nov 21 12:00 AM
Garner Todd WExecutive Vice President & CFONov 06 '25Sale43.003,500150,5001,836Nov 07 12:00 AM
Foust Hollie KGeneral Counsel & Corp SecNov 04 '25Option Exercise0.008,00004,000Nov 05 12:00 AM
Garner Todd WExecutive Vice President & CFOOct 31 '25Option Exercise0.0015,000015,227Nov 03 12:00 AM
Farkas CharlesDirectorSep 12 '25Sale53.522,000107,04914,859Sep 15 12:00 AM
Garner Todd WExecutive Vice President & CFOAug 07 '25Sale52.4559831,3650Aug 08 12:00 AM
Council LaVerne HDirectorJun 03 '25Option Exercise0.0095804,048Jun 04 12:00 AM
Schwarzentraub Barbara JDirectorJun 03 '25Option Exercise0.0095804,344Jun 04 12:00 AM
Concannon BrianDirectorJun 03 '25Option Exercise0.00958010,116Jun 04 12:00 AM
Farkas CharlesDirectorJun 03 '25Option Exercise0.00958016,859Jun 04 12:00 AM
Bronson David M.DirectorJun 03 '25Option Exercise0.00958017,241Jun 04 12:00 AM
Aronson Martha GoldbergDirectorJun 03 '25Option Exercise0.00958012,391Jun 04 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR